CHAMPIONS ONCOLOGY, INC. Operating Loss Carryforwards
CHAMPIONS ONCOLOGY, INC. (CSBR) had Operating Loss Carryforwards of $41.00 million as of 2026-04-30, per its 10-K filed 2026-07-27.
Financial Statements › Notes › Income Taxes
us-gaap:OperatingLossCarryforwards · last filed 2026-07-27
- 2026-04-30: Operating Loss Carryforwards $41.00M.
- 2025-04-30: Operating Loss Carryforwards $35.10M.
- 2024-04-30: Operating Loss Carryforwards $38.60M.
- 2023-04-30: Operating Loss Carryforwards $41.30M.
| Period end | Operating Loss Carryforwards |
|---|---|
| 2026-04-30 | $41.00M 10-K · filed 2026-07-27 |
| 2025-04-30 | $35.10M 10-K · filed 2026-07-27 |
| 2024-04-30 | $38.60M 10-K · filed 2025-07-23 |
| 2023-04-30 | $41.30M 10-K · filed 2024-07-19 |
| 2022-04-30 | $48.00M 10-K · filed 2023-07-24 |
| 2021-04-30 | $46.90M 10-K · filed 2022-07-22 |
| 2020-04-30 | $45.00M 10-K · filed 2021-07-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |